Call for Abstract

Cancer Diagnostics Conference & Expo, will be organized around the theme “Enhancing innovations in Cancer Diagnosis and treatment”

Cancer Diagnostics 2016 is comprised of 13 tracks and 96 sessions designed to offer comprehensive sessions that address current issues in Cancer Diagnostics 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Advanced diagnostics methods have achieved a reduction of 30% in mortality due to breast cancer. Hence, the imaging sector in the global cancer diagnostics market will continue its dominance in the foreseeable future. Application-wise, the global cancer diagnostics market is segmented into blood cancer, kidney cancer, colorectal cancer, breast cancer, prostate cancer, pancreatic cancer, ovarian cancer, lung cancer, and liver cancer.  Cancer Diagnostics 2016 is a very important meeting among global cancer Conferences 2016 .

  • Track 1-1Business of cancer diagnostics
  • Track 1-2Growth of cancer diagnostics
  • Track 1-3Recent trends in cancer diagnostics
  • Track 1-4Commercialization of molecular cancer diagnostics
  • Track 1-5Novel approaches in cancer diagnostics

A mammogram is an x-ray of the breast. While screening mammograms are routinely administered to detect breast cancer in women who have no apparent symptoms, diagnostic mammograms are used after suspicious results on a screening mammogram or after some signs of breast cancer alert the physician to check the tissue.

A breast biopsy is a test that removes tissue or sometimes fluid from the suspicious area. The removed cells are examined under a microscope and further tested to check for the presence of breast cancer. OMICS International Conferences is going to organize many Cancer Conferences 2016 worldwide with respect to different region.

  • Track 2-1Breast cancer diagnostics
  • Track 2-2Prostate cancer diagnostics
  • Track 2-3Lung cancer diagnostics
  • Track 2-4Ovarian cancer diagnostics
  • Track 2-5Prenatal molecular diagnostics
  • Track 2-6Oral Cancer Diagnostics

Prostate screening tests might include:

Digital rectal exam (DRE),  Prostate-specific antigen (PSA) test.

Mammograms can be used to check for breast cancer in women who have no signs or symptoms of the disease. Cancer screening Oncolytic virotherapy is an exciting, increasingly recognized discipline in cancer research which will be discussed in upcoming cancer conferences 2016.

  • Track 3-1Colonoscopy and Sigmoidoscopy
  • Track 3-2Liquid biopsy
  • Track 3-3 Cell free DNA
  • Track 3-4Bone marrow aspiration and biopsy
  • Track 3-5PSA test
  • Track 3-6CA-125 test
  • Track 3-7 Breast MRI
  • Track 3-8Alpha-fetoprotein blood test
  • Track 3-9 Pap test and human papillomavirus (HPV) testing
  • Track 3-10Mammography
  • Track 3-11Low-dose helical computed tomography
  • Track 3-12MUGA scan

Radiological tests can help doctors find and treat several types of cancer early. Early detection is important because when abnormal tissue or cancer is found early it may be easier to treat. By the time symptoms appear, cancer may have begun to spread and is harder to treat. . Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number of new cases diagnosed in 2012 and became an important topic for World Cancer Conferences.

  • Track 4-1Breast MRI for the early detection of breast cancer
  • Track 4-2Computed Tomography (CT) scan
  • Track 4-3EKG and echocardiogram
  • Track 4-4 Integrated PET-CT scan
  • Track 4-5Mammographic analysis
  • Track 4-6Positron Emission Tomography (PET) scan

Cancer nanotechnology is the burgeoning field of treatment of cancer with nanotechnology. It is applicable for cancer diagnosis, imaging, prognosis and therapy.  The nanoparticles selectively accumulate in the tumor cell by the mechanism of the enhanced permeability and retention effect. Thus, nanoparticles are suitable for delivering diagnostic and the imaging agents, chemo and gene drugs to the tumor. 

  • Track 5-1Cancer Microenvironment
  • Track 5-2Chemo Drugs
  • Track 5-3Stealth Nanoparticles and Tumor Penetrating Peptides
  • Track 5-4Vector/Host Interaction
  • Track 5-5Early Diagnosis and Imaging
  • Track 5-6Advances in Nanotechnology
  • Track 5-7Cancer Bioinformatics

Cancer rates continue to increase, particularly in the developed world. Many cancers are associated with longevity, and as life expectancy lengthens, the burden on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past decade are beginning to be translated into progress in cancer treatment. This progress is manifested by new cytotoxic drugs which have recently entered clinical practice. 

  • Track 6-1Cancer immunotherapy
  • Track 6-2Mass stem cells production technologies
  • Track 6-3Cancer stem cell markers
  • Track 6-4Hematopoietic cell, Bone marrow and stem cell transplantation
  • Track 6-5Stem cell transplantation for cancer treatment
  • Track 6-6New therapies with pleiotropic activity
  • Track 6-7Small oligonucleotides therapy
  • Track 6-8Hormone therapies & gene expression modulators
  • Track 6-9Genomic tumor assessment and tumor molecular profiling
  • Track 6-10Nanotechnology in cancer therapy
  • Track 6-11Metabolomics approach towards cancer therapy
  • Track 6-12Molecular targeted cancer therapy and precision medicines
  • Track 6-13Oral Cancer and its Treatment

The assessment of a typical biomarker in cancer helps in the development of therapies that can target the biomarker. 

 Certain DNA or RNA markers may therefore help in the detection and treatment of specific cancers.

  • Track 7-1Novel biomarkers in cancer diagnosis and prognosis
  • Track 7-2Imaging biomarkers
  • Track 7-3Genetic biomarkers
  • Track 7-4Detection and characterization of circulating biomarkers
  • Track 7-5Advanced biomarkers for cancer
  • Track 7-6Breast cancer biomarkers
  • Track 7-7Prostrate cancer biomarkers
  • Track 7-8Lung cancer biomarkers
  • Track 7-9Cancer stem cell markers
  • Track 7-10Glycoprotein biomarkers

Clinical genomics is the use of genome sequencing to inform patient diagnosis and care but there are already uses for genetic and genomic information in the clinic.  stratifying patients for appropriate cancer treatment; and providing information about an individual’s likely response to treatment to reduce adverse drug reactions.

  • Track 8-1Interrogating cancer genes with NGS-based approaches
  • Track 8-2Genotyping technologies
  • Track 8-3Data interpretation
  • Track 8-4Moving from technology to patient treatment
  • Track 8-5The evolving role of the patient
  • Track 8-6Cancer Epigenetics

There are many types of cancer treatment. The types of treatment that you have will depend on the type of cancer you have and how advanced it is. Some people with cancer will have only one treatment. 

  • Track 9-1Surgery
  • Track 9-2Radiation therapy
  • Track 9-3 Chemotherapy
  • Track 9-4Immunotherapy
  • Track 9-5Nanotechnology in cancer therapy
  • Track 9-6Targeted therapy
  • Track 9-7Stem cell transplant
  • Track 9-8Future of oncology treatment

A thorough and accurate cancer diagnosis is the first step in developing an individualized cancer treatment plan. When you first visit one of our hospitals, we will perform a complete array of diagnostic tests to accurately confirm your diagnosis and plan your individualized treatment.  Cancer conferences 2016 also focused on these topics.

  • Track 10-1Next-gen sequencing for diagnosis and monitoring of cancers
  • Track 10-2Camera pill technology & 3D printing technology in cancer detection
  • Track 10-3Non-invasive cancer diagnostics:  MR guided Focused Ultrasound Surgery
  • Track 10-4High resolution microendoscopy , CryoPen, cryotherapy device
  • Track 10-5Advancements in CT Scan, MRI Scan, Mammograms, Radiography etc.
  • Track 10-6 Image-guided photodynamic therapy of oral leukoplakia
  • Track 10-7Role of biobank establishment for cancer research & treatment
  • Track 10-8Clinical proteomics & metabolomics assays for cancer biomarkers discovery
  • Track 10-9Biomarkers in cancer diagnosis and prognosis
  • Track 10-10 Portable computer-aided detection and diagnostic (CADD) tools

The name of cancer is based on the location of cancer cells occur in particular organ.  There are more than 200 different types of cancer diagnosed. Among them Lung cancer, breast cancer are the most common cancer diagnosed cancer in 2015. Apart from these prostate cancers, colon cancers, bladder cancer are the most common type cancer. Depending upon the location of cancer the causes, symptoms and method of treatments varies. Carcinoma, Sarcoma, leukemia, lymphoma and melanoma are the types of cancer found in different organs

  • Track 11-1Breast Cancer
  • Track 11-2Lung Cancer
  • Track 11-3Skin Cancer
  • Track 11-4Pancreatic and Colorectal Cancer
  • Track 11-5Bone Cancer
  • Track 11-6Prostate Cancer
  • Track 11-7Head and Neck Cancers
  • Track 11-8Soft tissue Sarcomas
  • Track 11-9Gynaecology Oncology

The study of cancer is called Oncology. A person who specializes in the study of oncology and treating people with cancer is called an oncologist. An oncologist manages care and treatment once a person is diagnosed with cancer.

  • Track 12-1Oncologists in Europe
  • Track 12-2Oncologists in USA
  • Track 12-3Oncologists in Germany
  • Track 12-4 Oncologists in Asia

Clinical trials are research studies that involve people. Understanding what they are can help you decide if a clinical trial might be an option for you. Or maybe you have a friend or family member with cancer and are wondering if a clinical trial is right for them. Depending on product type and development stage, investigators initially enroll volunteers and/or patients into small pilot studies, and subsequently conduct progressively larger scale comparative studies. Clinical trials can vary in size and cost, and they can involve a single research center or multiple centers, in one country or in multiple countries. Clinical study design aims to ensure the scientific validity and reproducibility of the results. Cancer Diagnostics 2016 is a very prestigious gathering across global Cancer Conferences.